Abbott Introduces the Lingo Over-The-Counter Continuous Glucose Monitor in the US Market

Friday, 6 September 2024, 04:47

Abbott introduces the Lingo over-the-counter continuous glucose monitor (CGM) in the US. Priced at $49 for one 14-day sensor, this cost-effective solution offers competition against Dexcom's Stelo sensor. With easy accessibility and affordability, the Lingo CGM is set to revolutionize diabetes management.
LivaRava_Medicine_Default.png
Abbott Introduces the Lingo Over-The-Counter Continuous Glucose Monitor in the US Market

Overview of Abbott's Lingo CGM

Abbott has officially launched its Lingo over-the-counter continuous glucose monitor (CGM) in the United States. This innovative device is priced at a competitive rate of $49 for a single 14-day sensor or $89 on a monthly subscription basis.

Comparative Analysis with Competitors

The Lingo CGM offers a compelling alternative in the growing market for continuous glucose monitoring technologies. When compared to Dexcom's Stelo sensor, Abbott's approach emphasizes affordability while prioritizing user-friendly features.

Impact on Diabetes Management

  • The Lingo CGM enhances accessibility for individuals managing diabetes.
  • Cost-benefit analysis shows potential savings for users.
  • Provides a critical tool for real-time glucose monitoring.

The introduction of Abbott's Lingo CGM could signify a transformative leap in how diabetes management is approached, making monitoring more accessible and affordable.


This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.


Related posts


Newsletter

Subscribe to our newsletter for the most accurate and current medical news. Stay updated and deepen your understanding of medical advancements effortlessly.

Subscribe